Treace Medical Concepts (TMCI) Stock Forecast & Price Target

Compare

113 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TMCI Analyst Ratings

Hold

1 Buy

4 Hold

1 Sell

Based on 6 analysts giving stock ratings to

Treace

Medical Concepts

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TMCI Stock 12 Month Forecast

Average Price Target

$5.47

▲(91.26% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Treace Medical Concepts in the last 3 months. The average price target is $5.47 with a high forecast of $7.50 and a low forecast of $4.00. The average price target represents a 91.26% change from the last price of $2.86.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"3":"$3","5":"$5","7":"$7","9":"$9","11":"$11"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":7.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$7.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":5.47,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$5.47</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[3,5,7,9,11],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Feb<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.39,6.475384615384615,6.560769230769231,6.646153846153846,6.731538461538461,6.816923076923077,6.9023076923076925,6.987692307692307,7.073076923076923,7.158461538461538,7.243846153846154,7.329230769230769,7.414615384615384,{"y":7.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.39,6.319230769230769,6.248461538461538,6.177692307692308,6.106923076923077,6.036153846153846,5.965384615384615,5.894615384615384,5.823846153846153,5.7530769230769225,5.682307692307692,5.611538461538461,5.5407692307692304,{"y":5.47,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,6.39,6.206153846153846,6.022307692307692,5.838461538461538,5.654615384615385,5.47076923076923,5.286923076923077,5.103076923076923,4.919230769230769,4.735384615384615,4.5515384615384615,4.367692307692307,4.1838461538461535,{"y":4,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.78,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":8.78,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.44,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.05,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.94,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.15,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.34,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.74,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.02,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.34,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.17,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.32,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.39,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$7.50

Average Price Target$5.47

Lowest Price Target$4.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Richard Newitter

Truist Financial

$7→$4

Hold

39.86%

Upside

Reiterated

11/10/25

Treace Medical Concepts (TMCI) Receives a Hold from Truist FinancialPT $4 (v.$7) on Lower Est.'s ... Reiterate Hold.

Danielle Antalffy

UBS

$6.5→$5.85

Hold

104.55%

Upside

Reiterated

11/07/25

Treace Medical price target lowered to $5.85 from $6.50 at UBSTreace Medical price target lowered to $5.85 from $6.50 at UBS

Lilia-Celine (Lily) Lozada

J.P. Morgan

$8→$5

Sell

74.83%

Upside

Downgraded

11/07/25

Treace Medical downgraded to Underweight from Neutral at JPMorganTreace Medical downgraded to Underweight from Neutral at JPMorgan

Rick Wise

Stifel Nicolaus

$6→$5

Hold

74.83%

Upside

Reiterated

11/07/25

Treace Medical Concepts (TMCI) Gets a Hold from Stifel Nicolaus

Ryan Zimmerman

BTIG

―

Hold

―

Downgraded

11/07/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (NASDAQ: IONS) and Treace Medical Concepts (NASDAQ: TMCI)

Ben Haynor

Lake Street

$12→$7.5

Buy

162.24%

Upside

Reiterated

11/07/25

Treace Medical price target lowered to $7.50 from $12 at Lake StreetTreace Medical price target lowered to $7.50 from $12 at Lake Street

Kallum Titchmarsh

Morgan Stanley

$10

Hold

249.65%

Upside

Reiterated

05/09/25

Cautious Hold Rating for Treace Medical Concepts Amid Mixed Outlook and Revenue Uncertainty

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Richard Newitter

Truist Financial

$7→$4

Hold

39.86%

Upside

Reiterated

11/10/25

Treace Medical Concepts (TMCI) Receives a Hold from Truist FinancialPT $4 (v.$7) on Lower Est.'s ... Reiterate Hold.

Danielle Antalffy

UBS

$6.5→$5.85

Hold

104.55%

Upside

Reiterated

11/07/25

Treace Medical price target lowered to $5.85 from $6.50 at UBSTreace Medical price target lowered to $5.85 from $6.50 at UBS

Lilia-Celine (Lily) Lozada

J.P. Morgan

$8→$5

Sell

74.83%

Upside

Downgraded

11/07/25

Treace Medical downgraded to Underweight from Neutral at JPMorganTreace Medical downgraded to Underweight from Neutral at JPMorgan

Rick Wise

Stifel Nicolaus

$6→$5

Hold

74.83%

Upside

Reiterated

11/07/25

Treace Medical Concepts (TMCI) Gets a Hold from Stifel Nicolaus

Ryan Zimmerman

BTIG

―

Hold

―

Downgraded

11/07/25

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ionis Pharmaceuticals (NASDAQ: IONS) and Treace Medical Concepts (NASDAQ: TMCI)

Ben Haynor

Lake Street

$12→$7.5

Buy

162.24%

Upside

Reiterated

11/07/25

Treace Medical price target lowered to $7.50 from $12 at Lake StreetTreace Medical price target lowered to $7.50 from $12 at Lake Street

Kallum Titchmarsh

Morgan Stanley

$10

Hold

249.65%

Upside

Reiterated

05/09/25

Cautious Hold Rating for Treace Medical Concepts Amid Mixed Outlook and Revenue Uncertainty

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Treace Medical Concepts

1 Month

xxx

Success Rate

3/7 ratings generated profit

Average Return

+0.40%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 42.86% of your transactions generating a profit, with an average return of +0.40% per trade.

3 Months

xxx

Success Rate

1/7 ratings generated profit

Average Return

-25.94%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 14.29% of your transactions generating a profit, with an average return of -25.94% per trade.

1 Year

Ben HaynorLake Street

Success Rate

0/7 ratings generated profit

Average Return

-61.21%

reiterated a buy rating last month

Copying Ben Haynor's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -61.21% per trade.

2 Years

xxx

Success Rate

0/7 ratings generated profit

Average Return

-61.21%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -61.21% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TMCI Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TMCI has received 3 Buy Ratings, 9 Hold Ratings, and 1 Sell Ratings. TMCI average Analyst price target in the past 3 months is 5.47.

Each month's total comprises the sum of three months' worth of ratings.

TMCI Financial Forecast

TMCI Earnings Forecast

Next quarter’s earnings estimate for TMCI is -$0.15 with a range of -$0.17 to -$0.14. The previous quarter’s EPS was -$0.26. TMCI beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year TMCI has Performed in-line its overall industry.

TMCI Sales Forecast

Next quarter’s sales forecast for TMCI is $61.72M with a range of $61.43M to $61.84M. The previous quarter’s sales results were $50.21M. TMCI beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year TMCI has Performed in-line its overall industry.

TMCI Stock Forecast FAQ

What is TMCI’s average 12-month price target, according to analysts?

Based on analyst ratings, Treace Medical Concepts, Inc.’s 12-month average price target is 5.47.

What is TMCI’s upside potential, based on the analysts’ average price target?

Treace Medical Concepts, Inc. has 91.26% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TMCI a Buy, Sell or Hold?

Treace Medical Concepts, Inc. has a consensus rating of Hold which is based on 1 buy ratings, 4 hold ratings and 1 sell ratings.

What is Treace Medical Concepts, Inc.’s price target?

The average price target for Treace Medical Concepts, Inc. is 5.47. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $7.50 ,the lowest forecast is $4.00. The average price target represents 91.26% Increase from the current price of $2.86.

What do analysts say about Treace Medical Concepts, Inc.?

Treace Medical Concepts, Inc.’s analyst rating consensus is a Hold. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of TMCI?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Treace Medical Concepts (TMCI) Stock Forecast & Price Target

TMCI Analyst Ratings

TMCI Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Treace Medical Concepts

TMCI Analyst Recommendation Trends

TMCI Financial Forecast

TMCI Earnings Forecast

TMCI Sales Forecast

TMCI Stock Forecast FAQ

Detailed List of Analyst Forecasts